Narrow Results

Ferrochelatase (also known as PPIX ferrochelatase; Enzyme Commission number 4.9.9.1.1) catalyzes the insertion of ferrous iron into PPIX to form heme. This reaction unites the biochemically synchronized pathways of porphyrin synthesis and iron transport in nearly all living organisms. The ferrochelatases are an evolutionarily diverse family of enzymes with no more than six active site residues known to be perfectly conserved. The availability of over thirty different crystal structures, including many with bound metal ions or porphyrins, has added tremendously to our understanding of ferrochelatase structure and function. It is generally believed that ferrous iron is directly channeled to ferrochelatase in vivo, but the identity of the suspected chaperone remains uncertain despite much recent progress in this area. Identification of a conserved metal ion binding site at the base of the active site cleft may be an important clue as to how ferrochelatases acquire iron, and catalyze desolvation during transport to the catalytic site to complete heme synthesis.

Ferrochelatase, the terminal enzyme of the heme biosynthetic pathway, catalyzes the insertion of ferrous iron into protoporphyrin IX to give heme. Resonance Raman spectroscopy has been instrumental in defining the distortion (mode and extent) of the porphyrin substrate, which is a critical step in the catalytic mechanism of ferrochelatase. Saddling is the predominant porphyrin out-of-plane deformation induced upon binding to ferrochelatase. Our analysis demonstrated that the intensity of the γ₁₅ line, which is assigned to an out-of-plane porphyrin vibration, in resonance Raman spectra obtained for wild-type- and variant ferrochelatase-bound porphyrin, correlates with the saddling deformation undergone by the porphyrin substrate. Further analysis of the three dimensional X-ray structures of bacterial, human and yeast ferrochelatases and the type and extent of distortion of the protein-bound porphyrin substrate and inhibitors using normal structure decomposition, support the view that ferrochelatase catalysis involves binding of a distorted porphyrin substrate and releasing of a flatter, metalated porphyrin.

Ferrochelatase catalyzes the insertion of ferrous iron into protoporphyrin IX to generate heme. Despite recent research on the reaction mechanism of ferrochelatase, the precise roles and localization of individual active site residues in catalysis, particularly those involved in the insertion of the ferrous iron into the protoporphyrin IX substrate, remain controversial. One outstanding question is from which side of the macrocycle of the bound porphyin substrate is the ferrous iron substrate inserted. Pre-steady state kinetic experiments done under single-turnover conditions conclusively demonstrate that metal ion insertion is pH-dependent, and that the conserved active site His-Glu pair coordinately catalyzes the metal ion insertion reaction. Further, p$K_a$ calculations and molecular dynamic simulations indicate that the active site His is deprotonated and the protonation state of the Glu relates to the conformational state of ferrochelatase. Specifically, the conserved Glu in the open conformation of ferrochelatase is deprotonated, while it remains protonated in the closed conformation. These findings support not only the role of the His-Glu pair in catalyzing metal ion insertion, as these residues need to be deprotonated to bind the incoming metal ion, but also the importance of the relationship between the protonation state of the Glu residue and the conformation of ferrochelatase. Finally, the results of this study are consistent with our previous proposal that the unwinding of the $\pi$-helix, the major structural determinant of the closed to open conformational transition in ferrochelatase, is associated with the Glu residue binding the Fe${}^{2+}$ substrate from a mitochondrial Fe${}^{2+}$ donor.

This short review highlights the author’s group research on modified vitamin B${}_{12}$ derivatives with a peptide backbone as (1) inhibitors of B${}_{12}$-dependent enzymes and as (2) models of cofactor B${}_{12}$-protein complexes.

miRNA-21 (miR-21) is a potential biomarker for the monitoring of diseases through its expression levels. Simple, portable and sensitive miR-21 detection of is advantageous for health monitoring in Point of Care Testing (POCT). Gold nanoparticles (AuNP) as excellent colorimetric sensors are widely used in the POCT. However, their low sensitivity is a limitation of their clinical use. Herein, we developed an AuNPs-based miR-21 assay with enzyme-assisted amplification reaction to construct the colorimetric platform capable of detecting as low as 0.1nM. In this platform, template ssDNA as a signal molecule could hybridize with ssDNA-modified AuNPs to generate the color reaction. The target miR-21 specifically hybridized to the template ssDNA, which was then cleaved by exonuclease III (Exo III) to release the target miR-21. As a trigger, miR-21 catalyzed the degradation of the template ssDNA to amplify the signal by Exo III. By hybridizing miR-21 and template ssDNA in the presence of Exo III, R-21 induced a significant decrease in the level of template ssDNA to reduce the aggregation of AuNPs. There is a clear color difference in the presence/absence of miR-21 in the assay. In this assay, the optimal concentration of templated ssDNA and Exo III were 100nM and 0.06U/$\mu$L in a 100$\mu$L detection system. The LoD for UV–Vis spectrum and colorimetric reaction were 0.1nM and 0.5nM, respectively. The detection system has good selectivity and can be used to detect miR-21 in the simulated saliva. It has great potential for application in biomedical research as well as in clinical diagnostics.

The sun is the only source of renewable energy available to us, if geothermal energy is not taken into account. In the form of radiation (UV light, visible light, infrared light, Section 1.1) it sends us annually 178,000 terawatts (1 TW = 10¹² W; unit of power 1 W = 1 J s^–1 = 859.85 calories per hour), that is to say 15,000 times the energy consumed annually by humanity. Only 0.1% of the solar energy received by planet Earth is converted into plant biomass, i.e. 100 × 10⁹ tons per year which corresponds to ca. 180 × 10⁹ tons per year of CO₂ captured from the atmosphere. This CO₂ returns to the biosphere after the death of the plants. Consumption of fossil carbon emits ca. 35 × 10⁹ tons of CO₂ yearly. Biomass is the material produced by all living organisms (plants, animals, microorganisms, fungi)…

Nowadays, textile processing based on biotechnology have gained importance in view of stringent environmental and industrial safety conditions. The use of protease enzymes on protein fibers to improve some physical and mechanical properties is particularly interesting.

In this research, wool yarns were first treated with different concentrations of protease enzymes in water solution including 1%, 2%, 4% and 6% o.w.f. for 60 minutes. The dyeing process was then carried out on the treated yarns with pistachio hulls (50% o.w.f.). Some of physical, mechanical and colorimetric properties of treated wool yarns were discussed. Tensile strength of treated yarns was decreased due to enzyme treatment and it continued to decrease with an increase in enzyme concentration in solution. The lightness was decreased for the samples treated with enzyme. The wash and light fastness properties of samples were measured according to ISO 105-CO5 and Daylight ISO 105-BO1. The washing fastness properties of treated samples were not changed. In the case of light fastness properties, it was increased a little for 4% and 6% enzyme treated samples.